Detection of minimal residual disease in blood and bone marrow in early stage breast cancer
β Scribed by Savitri Krishnamurthy; Massimo Cristofanilli; Balraj Singh; James Reuben; Hui Gao; Evan N. Cohen; Eleni Andreopoulou; Carolyn S. Hall; Ashutosh Lodhi; Summer Jackson; Anthony Lucci
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 186 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. We have determined whether sequential molecular detection of minimal residual disease (MRD) in bone marrow (BM) could predict the outcome of patients with advanced neuroblastoma (NB). Procedure. Bone marrow samples from 19 patients over 12 months of age with stage 4 neuroblastoma were se
## Abstract Immunocytochemical (ICC) detection of disseminated tumor cells (DTC) in bone marrow (BM) in early breast cancer is an independent prognostic factor. The significance of circulating tumor cells (CTC) in peripheral blood (PB) needs further exploration and comparison to DTC detection. PB a
## Abstract Tumor tissues, blood plasma and bone marrow (BM) aspirates of 57 prostate cancer patients (PCa) without clinical signs of overt metastases were assessed for LOH (loss of heterozygosity) by a PCRβbased fluorescence microsatellite analysis, using a panel of 15 markers. Additionally, micro